Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By stimulating these https://tednwbg919262.blog4youth.com/36883030/tirzepatide-a-promising-new-treatment-for-obesity